OLMA OLEMA PHARMACEUTICALS INC Management Changes 8-K Filing 2023 - Amendment and Appointment Olema Pharmaceuticals, Inc. filed an amendment to correct a typographical error and the item number in their previous filing, and announced the appointment of Scott Garland as a Class III director and member of the Compensation Committee.Get access to all SEC 8-K filings of the OLEMA PHARMACEUTICALS INC